Ionis Pharmaceuticals, Inc. (BMV:IONS)

Ionis Pharmaceuticals Statistics

Total Valuation

BMV:IONS has a market cap or net worth of MXN 209.73 billion. The enterprise value is 208.58 billion.

Market Cap	209.73B
Enterprise Value	208.58B

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	159.39M
Shares Outstanding	n/a
Shares Change (YoY)	+7.02%
Shares Change (QoQ)	+1.40%
Owned by Insiders (%)	0.74%
Owned by Institutions (%)	103.96%
Float	163.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.34
PB Ratio	23.82
P/TBV Ratio	23.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-30.38
EV / Sales	12.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-36.20

Financial Position

The company has a current ratio of 3.83, with a Debt / Equity ratio of 5.35.

Current Ratio	3.83
Quick Ratio	3.51
Debt / Equity	5.35
Debt / EBITDA	n/a
Debt / FCF	-8.17
Interest Coverage	-4.22

Financial Efficiency

Return on equity (ROE) is -70.80% and return on invested capital (ROIC) is -90.05%.

Return on Equity (ROE)	-70.80%
Return on Assets (ROA)	-7.31%
Return on Invested Capital (ROIC)	-90.05%
Return on Capital Employed (ROCE)	-13.92%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	12.12M
Profits Per Employee	-4.90M
Employee Count	1,402
Asset Turnover	0.29
Inventory Turnover	82.58

Taxes

In the past 12 months, BMV:IONS has paid 32.15 million in taxes.

Income Tax	32.15M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.78% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+27.78%
50-Day Moving Average	907.28
200-Day Moving Average	n/a
Relative Strength Index (RSI)	63.61
Average Volume (20 Days)	785

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.95

Income Statement

In the last 12 months, BMV:IONS had revenue of MXN 16.99 billion and -6.87 billion in losses. Loss per share was -42.91.

Revenue	16.99B
Gross Profit	219.33M
Operating Income	-6.87B
Pretax Income	-6.83B
Net Income	-6.87B
EBITDA	-6.65B
EBIT	-6.87B
Loss Per Share	-42.91

Balance Sheet

The company has 48.26 billion in cash and 47.09 billion in debt, with a net cash position of 1.16 billion.

Cash & Cash Equivalents	48.26B
Total Debt	47.09B
Net Cash	1.16B
Net Cash Per Share	n/a
Equity (Book Value)	8.81B
Book Value Per Share	53.92
Working Capital	39.77B

Cash Flow

In the last 12 months, operating cash flow was -4.84 billion and capital expenditures -926.16 million, giving a free cash flow of -5.76 billion.

Operating Cash Flow	-4.84B
Capital Expenditures	-926.16M
Depreciation & Amortization	222.76M
Net Borrowing	8.99B
Free Cash Flow	-5.76B
FCF Per Share	n/a

Margins

Gross margin is 1.29%, with operating and profit margins of -40.45% and -40.41%.

Gross Margin	1.29%
Operating Margin	-40.45%
Pretax Margin	-40.22%
Profit Margin	-40.41%
EBITDA Margin	-39.13%
EBIT Margin	-40.45%
FCF Margin	n/a

Dividends & Yields

BMV:IONS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.02%
Shareholder Yield	-7.02%
Earnings Yield	-3.27%
FCF Yield	-2.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:IONS has an Altman Z-Score of 1.13 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.13
Piotroski F-Score	3